Department of Pharmacy, China-Japan Friendship Hospital, Beijing, China.
National Center for Respiratory Medicine, State Key Laboratory of Respiratory Health and Multimorbidity, National Clinical Research Center for Respiratory Diseases, Institute of Respiratory Medicine, Chinese Academy of Medical Sciences; Department of Lung Transplantation, Center of Respiratory Medicine, China-Japan Friendship Hospital, Beijing, China.
Ren Fail. 2024 Dec;46(2):2406403. doi: 10.1080/0886022X.2024.2406403. Epub 2024 Sep 20.
The purpose of this study was to investigate the correlation between different subtypes of acute kidney injury (AKI) and clinical outcomes following lung transplantation (LTx) and to identify a reliable indicator for predicting poor prognosis in the LTx population.
We retrospectively analyzed the clinical data of 279 LTx patients from August 2016 to March 2023. The AKI subtypes included AKI, persistent AKI on Day 7 (P7-AKI) and Day 14 (P14-AKI) after LTx, and AKI stages. The correlations of these factors with respiratory outcomes, mortality at 90 days, mortality at 1 year and data finalization were assessed, and the risk factors for the selected AKI subtypes were evaluated.
AKI occurred in 215 patients (77.1%), with 129 (46.2%) experiencing P7-AKI and 95 (34.1%) experiencing P14-AKI. P7-AKI was associated with more respiratory and mortality outcomes than were AKI and AKI stages, and P7-AKI surpassed P14-AKI in terms of a shorter diagnostic time. After adjusting for age, sex, BMI, type of transplant, transplant diagnosis and comorbidities, P7-AKI independently correlated with increased mortality risk at 90 days [HR 12.312 (95% CI: 2.839-53.402)], 1 year [HR 3.847 (95% CI: 1.840-8.044)], and data finalization [HR 2.010 (95% CI: 1.331-3.033)]. Five variables were identified as independent predictors for P7-AKI, including preoperative body mass index, prothrombin activity, hemoglobin and serum creatinine, and intraoperative colloid administration.
P7-AKI has been identified as a reliable indicator for predicting adverse outcomes in LTx patients, which may assist healthcare professionals in identifying high-risk individuals.
本研究旨在探讨急性肾损伤(AKI)不同亚型与肺移植(LTx)后临床结局的相关性,并确定一个可靠的指标来预测 LTx 人群的不良预后。
我们回顾性分析了 2016 年 8 月至 2023 年 3 月期间 279 例 LTx 患者的临床资料。AKI 亚型包括 LTx 后第 7 天(P7-AKI)和第 14 天(P14-AKI)的 AKI、持续 AKI 以及 AKI 分期。评估了这些因素与呼吸结局、90 天死亡率、1 年死亡率和数据截止时的相关性,并评估了选定 AKI 亚型的危险因素。
215 例患者(77.1%)发生 AKI,其中 129 例(46.2%)发生 P7-AKI,95 例(34.1%)发生 P14-AKI。与 AKI 和 AKI 分期相比,P7-AKI 与更多的呼吸和死亡率结局相关,并且 P7-AKI 在诊断时间更短方面超过了 P14-AKI。在校正年龄、性别、BMI、移植类型、移植诊断和合并症后,P7-AKI 与 90 天死亡率增加独立相关[HR 12.312(95%CI:2.839-53.402)]、1 年死亡率增加[HR 3.847(95%CI:1.840-8.044)]和数据截止时死亡率增加[HR 2.010(95%CI:1.331-3.033)]。5 个变量被确定为 P7-AKI 的独立预测因子,包括术前体重指数、凝血酶原活性、血红蛋白和血清肌酐以及术中胶体的使用。
P7-AKI 已被确定为预测 LTx 患者不良结局的可靠指标,这可能有助于医疗保健专业人员识别高风险个体。